Filing Details

Accession Number:
0001209191-19-019985
Form Type:
4
Zero Holdings:
No
Publication Time:
2019-03-18 16:16:19
Reporting Period:
2019-03-14
Accepted Time:
2019-03-18 16:16:19
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
885978 U S Physical Therapy Inc USPH Services-Health Services (8000) 760364866
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1315304 Glenn Mcdowell 1300 W Sam Houston Pkwy S
Suite 300
Houston TX 77042
Chief Operating Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2019-03-14 400 $112.48 30,702 No 4 S Direct
Common Stock Disposition 2019-03-15 405 $110.10 30,297 No 4 S Direct
Common Stock Disposition 2019-03-18 5,399 $106.63 24,898 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
No 4 S Direct
Footnotes
  1. The price reported is a weighted average price. The shares were sold in multiple transactions at prices ranging from $112.44 to $112.49 per share, both inclusive. The reporting person undertakes to provide to U.S. Physical Therapy, Inc., any of its shareholders or the staff of the Securities & Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4.
  2. Includes 24,898 shares of restricted stock granted under the Company's equity plans. Restrictions lapse as to 2,500 shares on each of April 1, 2019, July 1, 2019, October 1, 2019 and January 1, 2020; 1,790 shares on each of April 1, July 1 and October 1, 2020; 1,805 shares on January 1, 2021; 1,280 shares on each of April 1, July 1 and October 1, 2021 and 1,288 shares on January 1, 2022; 648 on each of April 1, July 1 and October 1, 2022; and 651 on January 1, 2023.
  3. The price reported is a weighted average price. The shares were sold in multiple transactions at prices ranging from $106.00 to $107.37 per share, both inclusive. The reporting person undertakes to provide to U.S. Physical Therapy, Inc., any of its shareholders or the staff of the Securities & Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4.